A Step Closer to Meeting the Threat of Avian Influenza
Open Access
- 12 September 2006
- journal article
- editorial
- Published by Public Library of Science (PLoS) in PLoS Medicine
- Vol. 3 (9) , e375
- https://doi.org/10.1371/journal.pmed.0030375
Abstract
Schultz-Cherry discusses a new study that describes the generation of live, attenuated H5N1 influenza viruses that may be suitable candidates for use in humans.Keywords
This publication has 13 references indexed in Scilit:
- Safety and Immunogenicity of an Inactivated Subvirion Influenza A (H5N1) VaccineNew England Journal of Medicine, 2006
- Making Better Influenza Virus Vaccines?Emerging Infectious Diseases, 2006
- Avian Influenza Virus Infections in HumansChest, 2006
- Avian Influenza A (H5N1) Infection in HumansNew England Journal of Medicine, 2005
- Responsiveness to a pandemic alert: use of reverse genetics for rapid development of influenza vaccinesThe Lancet, 2004
- Evaluation of a Genetically Modified Reassortant H5N1 Influenza A Virus Vaccine Candidate Generated by Plasmid-Based Reverse GeneticsVirology, 2003
- Safety, efficacy and effectiveness of cold-adapted, live, attenuated, trivalent, intranasal influenza vaccine in adults and childrenPhilosophical Transactions Of The Royal Society B-Biological Sciences, 2001
- Safety and antigenicity of non-adjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a randomised trial of two potential vaccines against H5N1 influenzaThe Lancet, 2001
- Safety and immunogenicity of a recombinant hemagglutinin vaccine for H5 influenza in humansVaccine, 2001
- Recombinant Influenza A Virus Vaccines for the Pathogenic Human A/Hong Kong/97 (H5N1) VirusesThe Journal of Infectious Diseases, 1999